Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Lymphocytic, Chronic, B-Cell | 74 | 2024 | 1640 | 14.060 |
Why?
|
Cancer Vaccines | 25 | 2024 | 1051 | 5.430 |
Why?
|
Antigens, Neoplasm | 36 | 2024 | 1993 | 5.230 |
Why?
|
Hematopoietic Stem Cell Transplantation | 40 | 2024 | 5671 | 3.460 |
Why?
|
Immunotherapy | 26 | 2024 | 4652 | 2.570 |
Why?
|
Single-Cell Analysis | 18 | 2024 | 2449 | 2.380 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 9 | 2023 | 1405 | 2.210 |
Why?
|
T-Lymphocytes | 28 | 2024 | 10194 | 2.160 |
Why?
|
Neoplasms | 45 | 2024 | 22170 | 2.120 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 15 | 2013 | 686 | 2.080 |
Why?
|
Lymphocyte Transfusion | 12 | 2021 | 232 | 2.030 |
Why?
|
Mutation | 52 | 2024 | 30052 | 2.000 |
Why?
|
Leukemia, Myeloid, Acute | 10 | 2024 | 3613 | 1.730 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 14 | 2022 | 1092 | 1.690 |
Why?
|
B-Lymphocytes | 24 | 2024 | 4758 | 1.590 |
Why?
|
CD8-Positive T-Lymphocytes | 21 | 2024 | 4580 | 1.590 |
Why?
|
Leukemia | 7 | 2024 | 1522 | 1.540 |
Why?
|
Transplantation, Homologous | 24 | 2024 | 4806 | 1.520 |
Why?
|
Graft vs Leukemia Effect | 9 | 2024 | 121 | 1.440 |
Why?
|
Immunotherapy, Adoptive | 11 | 2023 | 1469 | 1.430 |
Why?
|
Gene Expression Regulation, Leukemic | 9 | 2024 | 651 | 1.410 |
Why?
|
DNA, Mitochondrial | 4 | 2024 | 865 | 1.400 |
Why?
|
Hematologic Neoplasms | 11 | 2021 | 1896 | 1.330 |
Why?
|
Sulfonamides | 5 | 2022 | 1978 | 1.330 |
Why?
|
DNA, Neoplasm | 4 | 2020 | 1745 | 1.310 |
Why?
|
Melanoma | 15 | 2024 | 5709 | 1.280 |
Why?
|
Tumor Escape | 5 | 2020 | 370 | 1.270 |
Why?
|
High-Throughput Nucleotide Sequencing | 13 | 2024 | 3639 | 1.160 |
Why?
|
Gene Expression Regulation, Neoplastic | 17 | 2024 | 8547 | 1.060 |
Why?
|
Pyrimidines | 12 | 2020 | 3028 | 1.060 |
Why?
|
Graft vs Host Disease | 18 | 2024 | 3029 | 1.020 |
Why?
|
CD4-Positive T-Lymphocytes | 12 | 2024 | 4369 | 0.990 |
Why?
|
Tumor Microenvironment | 20 | 2024 | 3877 | 0.980 |
Why?
|
Histocompatibility Antigens Class I | 6 | 2021 | 1349 | 0.980 |
Why?
|
Bone Marrow Transplantation | 14 | 2023 | 2693 | 0.980 |
Why?
|
Genomics | 20 | 2024 | 5821 | 0.950 |
Why?
|
Humans | 252 | 2024 | 761504 | 0.950 |
Why?
|
Phosphoproteins | 8 | 2023 | 2448 | 0.930 |
Why?
|
DNA Barcoding, Taxonomic | 2 | 2023 | 132 | 0.930 |
Why?
|
Gene Expression Profiling | 17 | 2024 | 9420 | 0.920 |
Why?
|
Pyrazoles | 6 | 2020 | 2009 | 0.920 |
Why?
|
Alternative Splicing | 5 | 2020 | 1093 | 0.910 |
Why?
|
Protein Array Analysis | 6 | 2012 | 400 | 0.910 |
Why?
|
Transplantation Chimera | 7 | 2008 | 594 | 0.860 |
Why?
|
Receptors, Antigen, T-Cell | 10 | 2024 | 2547 | 0.850 |
Why?
|
Carcinoma, Renal Cell | 10 | 2023 | 3164 | 0.840 |
Why?
|
Drug Resistance, Neoplasm | 13 | 2024 | 5305 | 0.840 |
Why?
|
Epitopes | 6 | 2021 | 2503 | 0.830 |
Why?
|
Antigen Presentation | 9 | 2023 | 1251 | 0.830 |
Why?
|
Evolution, Molecular | 5 | 2019 | 1886 | 0.830 |
Why?
|
Sequence Analysis, DNA | 7 | 2020 | 4740 | 0.800 |
Why?
|
Ikaros Transcription Factor | 2 | 2021 | 232 | 0.780 |
Why?
|
Neoplasm Recurrence, Local | 11 | 2023 | 9280 | 0.740 |
Why?
|
Data Mining | 4 | 2013 | 551 | 0.730 |
Why?
|
Disease Progression | 9 | 2023 | 13506 | 0.700 |
Why?
|
Protein-Tyrosine Kinases | 6 | 2023 | 2425 | 0.690 |
Why?
|
Epigenesis, Genetic | 9 | 2023 | 3802 | 0.690 |
Why?
|
Lymphoproliferative Disorders | 1 | 2023 | 531 | 0.680 |
Why?
|
HLA Antigens | 10 | 2022 | 1328 | 0.670 |
Why?
|
Myelodysplastic Syndromes | 4 | 2024 | 1394 | 0.660 |
Why?
|
Quinazolinones | 3 | 2019 | 221 | 0.650 |
Why?
|
Anemia, Sickle Cell | 6 | 2019 | 1063 | 0.650 |
Why?
|
Receptors, Notch | 2 | 2021 | 743 | 0.650 |
Why?
|
Spliceosomes | 3 | 2018 | 130 | 0.650 |
Why?
|
Epitopes, T-Lymphocyte | 5 | 2014 | 828 | 0.640 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2023 | 2825 | 0.640 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 9 | 2022 | 11742 | 0.640 |
Why?
|
Kidney Neoplasms | 8 | 2022 | 4249 | 0.630 |
Why?
|
Lymphocyte Activation | 7 | 2024 | 5486 | 0.630 |
Why?
|
Neoplasm Proteins | 6 | 2021 | 3617 | 0.620 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2018 | 85 | 0.620 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2023 | 1374 | 0.610 |
Why?
|
Epoxy Compounds | 1 | 2018 | 137 | 0.610 |
Why?
|
RNA, Neoplasm | 1 | 2020 | 750 | 0.600 |
Why?
|
Stem Cell Transplantation | 3 | 2021 | 1600 | 0.590 |
Why?
|
Lymphocyte Depletion | 4 | 2013 | 602 | 0.590 |
Why?
|
Purines | 3 | 2019 | 607 | 0.580 |
Why?
|
Adoptive Transfer | 1 | 2020 | 819 | 0.580 |
Why?
|
Macrolides | 1 | 2018 | 205 | 0.580 |
Why?
|
Glioblastoma | 7 | 2023 | 3482 | 0.570 |
Why?
|
Substrate Specificity | 1 | 2021 | 1791 | 0.570 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2021 | 988 | 0.560 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2023 | 1405 | 0.550 |
Why?
|
Melanoma-Specific Antigens | 2 | 2018 | 74 | 0.550 |
Why?
|
Receptors, Antigen, B-Cell | 4 | 2023 | 545 | 0.550 |
Why?
|
Mice | 38 | 2024 | 81525 | 0.540 |
Why?
|
Chromatin | 6 | 2023 | 2960 | 0.540 |
Why?
|
Animals | 53 | 2024 | 168459 | 0.530 |
Why?
|
Mitochondria | 5 | 2023 | 3624 | 0.520 |
Why?
|
Adenine | 7 | 2022 | 987 | 0.510 |
Why?
|
Peptides | 7 | 2022 | 4358 | 0.510 |
Why?
|
Epigenomics | 3 | 2017 | 943 | 0.500 |
Why?
|
Clone Cells | 7 | 2022 | 1659 | 0.500 |
Why?
|
Antigens, Surface | 3 | 2010 | 1606 | 0.470 |
Why?
|
Fusion Proteins, bcr-abl | 6 | 2012 | 431 | 0.470 |
Why?
|
Validation Studies as Topic | 2 | 2012 | 162 | 0.450 |
Why?
|
Monitoring, Immunologic | 4 | 2021 | 98 | 0.450 |
Why?
|
Ribonucleoprotein, U2 Small Nuclear | 1 | 2013 | 21 | 0.440 |
Why?
|
Databases, Genetic | 6 | 2019 | 1742 | 0.430 |
Why?
|
Cell Lineage | 6 | 2024 | 2555 | 0.430 |
Why?
|
Skin Neoplasms | 7 | 2023 | 5821 | 0.420 |
Why?
|
Piperidines | 7 | 2022 | 1656 | 0.420 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1787 | 0.420 |
Why?
|
Oncolytic Virotherapy | 1 | 2018 | 516 | 0.410 |
Why?
|
Tissue Donors | 8 | 2024 | 2331 | 0.410 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2017 | 774 | 0.400 |
Why?
|
Erythropoiesis | 4 | 2016 | 683 | 0.390 |
Why?
|
DNA Methylation | 9 | 2021 | 4398 | 0.390 |
Why?
|
Tandem Mass Spectrometry | 2 | 2021 | 1188 | 0.390 |
Why?
|
Transplantation Conditioning | 5 | 2013 | 1590 | 0.380 |
Why?
|
Base Sequence | 4 | 2020 | 12441 | 0.380 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2023 | 3602 | 0.370 |
Why?
|
Algorithms | 10 | 2020 | 14031 | 0.370 |
Why?
|
Transcription, Genetic | 5 | 2021 | 7594 | 0.370 |
Why?
|
Recurrence | 11 | 2023 | 8465 | 0.370 |
Why?
|
Cell Line, Tumor | 14 | 2024 | 16981 | 0.370 |
Why?
|
Antineoplastic Agents | 14 | 2023 | 13639 | 0.360 |
Why?
|
Signal Transduction | 15 | 2023 | 23445 | 0.360 |
Why?
|
Germ-Line Mutation | 2 | 2018 | 1858 | 0.360 |
Why?
|
Polyomavirus Infections | 2 | 2023 | 194 | 0.360 |
Why?
|
Leukocytes, Mononuclear | 5 | 2022 | 1844 | 0.350 |
Why?
|
beta Catenin | 2 | 2015 | 1040 | 0.340 |
Why?
|
Education | 1 | 2013 | 537 | 0.340 |
Why?
|
DNA Copy Number Variations | 7 | 2021 | 2020 | 0.340 |
Why?
|
Tumor Cells, Cultured | 9 | 2022 | 6132 | 0.340 |
Why?
|
K562 Cells | 5 | 2013 | 642 | 0.330 |
Why?
|
Ploidies | 2 | 2024 | 285 | 0.330 |
Why?
|
Antigen-Antibody Complex | 1 | 2011 | 510 | 0.330 |
Why?
|
Disease Models, Animal | 6 | 2023 | 18252 | 0.330 |
Why?
|
Protein Kinase Inhibitors | 7 | 2023 | 5671 | 0.320 |
Why?
|
Databases, Protein | 3 | 2019 | 387 | 0.320 |
Why?
|
Toll-Like Receptors | 2 | 2020 | 589 | 0.320 |
Why?
|
Female | 74 | 2024 | 392644 | 0.320 |
Why?
|
Middle Aged | 52 | 2024 | 220895 | 0.310 |
Why?
|
Male | 63 | 2024 | 360804 | 0.310 |
Why?
|
Immunoprecipitation | 1 | 2011 | 878 | 0.310 |
Why?
|
Hemolysis | 2 | 2007 | 415 | 0.310 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2023 | 328 | 0.310 |
Why?
|
Vaccination | 8 | 2024 | 3384 | 0.300 |
Why?
|
Congresses as Topic | 1 | 2012 | 803 | 0.290 |
Why?
|
Apoptosis | 9 | 2023 | 9486 | 0.290 |
Why?
|
Immunity | 2 | 2023 | 996 | 0.290 |
Why?
|
Protein Interaction Mapping | 1 | 2011 | 616 | 0.280 |
Why?
|
Immunophenotyping | 3 | 2022 | 1870 | 0.280 |
Why?
|
Adult | 47 | 2024 | 221177 | 0.280 |
Why?
|
Mice, Inbred NOD | 2 | 2021 | 1827 | 0.280 |
Why?
|
Genomic Instability | 3 | 2021 | 709 | 0.270 |
Why?
|
Erythroid Cells | 1 | 2008 | 238 | 0.270 |
Why?
|
Immunologic Memory | 4 | 2021 | 1359 | 0.270 |
Why?
|
Indoles | 1 | 2014 | 1833 | 0.270 |
Why?
|
Phenotype | 6 | 2024 | 16591 | 0.270 |
Why?
|
Mice, Transgenic | 6 | 2023 | 9539 | 0.260 |
Why?
|
Genetic Heterogeneity | 4 | 2024 | 732 | 0.260 |
Why?
|
Genome | 1 | 2014 | 1740 | 0.260 |
Why?
|
beta-Thalassemia | 1 | 2008 | 236 | 0.260 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2021 | 293 | 0.250 |
Why?
|
Piperazines | 6 | 2020 | 2523 | 0.250 |
Why?
|
Neuroblastoma | 2 | 2024 | 1250 | 0.250 |
Why?
|
Prognosis | 16 | 2024 | 29625 | 0.250 |
Why?
|
T-Lymphocytes, Cytotoxic | 5 | 2024 | 1784 | 0.250 |
Why?
|
Neoplasms, Experimental | 2 | 2021 | 1229 | 0.250 |
Why?
|
Erythroblasts | 1 | 2005 | 142 | 0.240 |
Why?
|
Antigen-Presenting Cells | 5 | 2023 | 964 | 0.240 |
Why?
|
Myeloid Progenitor Cells | 1 | 2005 | 113 | 0.240 |
Why?
|
Computational Biology | 6 | 2020 | 3518 | 0.240 |
Why?
|
Cell Communication | 3 | 2024 | 1657 | 0.240 |
Why?
|
Graft Survival | 5 | 2011 | 3819 | 0.240 |
Why?
|
Siblings | 1 | 2008 | 825 | 0.230 |
Why?
|
Proteome | 4 | 2019 | 1862 | 0.230 |
Why?
|
Cytokines | 5 | 2023 | 7396 | 0.230 |
Why?
|
Models, Biological | 2 | 2019 | 9469 | 0.230 |
Why?
|
Genetic Variation | 3 | 2015 | 6567 | 0.230 |
Why?
|
Living Donors | 1 | 2008 | 641 | 0.230 |
Why?
|
Sequence Analysis, RNA | 6 | 2024 | 2020 | 0.220 |
Why?
|
Immune System | 6 | 2022 | 796 | 0.220 |
Why?
|
Polymerase Chain Reaction | 7 | 2019 | 6075 | 0.220 |
Why?
|
NF-kappa B | 2 | 2023 | 2490 | 0.220 |
Why?
|
MELAS Syndrome | 1 | 2024 | 56 | 0.220 |
Why?
|
Genome, Human | 6 | 2023 | 4425 | 0.220 |
Why?
|
Isoantigens | 1 | 2006 | 551 | 0.220 |
Why?
|
Antibodies, Neoplasm | 3 | 2002 | 281 | 0.220 |
Why?
|
Herpesvirus 6, Human | 1 | 2023 | 96 | 0.210 |
Why?
|
Genes, myc | 2 | 2015 | 390 | 0.210 |
Why?
|
Gene Library | 5 | 2011 | 1059 | 0.210 |
Why?
|
Immunity, Innate | 3 | 2022 | 3065 | 0.210 |
Why?
|
RNA Splicing | 3 | 2018 | 918 | 0.210 |
Why?
|
Periodicals as Topic | 2 | 2012 | 1463 | 0.200 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2024 | 755 | 0.200 |
Why?
|
Antigens, CD34 | 1 | 2024 | 658 | 0.200 |
Why?
|
Cell-Penetrating Peptides | 1 | 2022 | 49 | 0.200 |
Why?
|
RNA, Messenger | 7 | 2022 | 12795 | 0.200 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2024 | 779 | 0.200 |
Why?
|
Blood | 1 | 2024 | 596 | 0.200 |
Why?
|
Endogenous Retroviruses | 2 | 2020 | 111 | 0.200 |
Why?
|
Neoplastic Stem Cells | 1 | 2010 | 1347 | 0.200 |
Why?
|
Treatment Outcome | 14 | 2023 | 64680 | 0.200 |
Why?
|
Multiple Myeloma | 5 | 2015 | 5146 | 0.190 |
Why?
|
Virus Activation | 1 | 2023 | 322 | 0.190 |
Why?
|
Down-Regulation | 2 | 2020 | 2919 | 0.190 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2023 | 2865 | 0.190 |
Why?
|
Statistics as Topic | 1 | 2008 | 2358 | 0.190 |
Why?
|
Graft vs Host Reaction | 1 | 2021 | 102 | 0.190 |
Why?
|
Daptomycin | 1 | 2021 | 71 | 0.190 |
Why?
|
Antibodies, Monoclonal | 4 | 2022 | 9177 | 0.190 |
Why?
|
Transplantation, Autologous | 3 | 2021 | 2115 | 0.190 |
Why?
|
High-Throughput Screening Assays | 2 | 2020 | 934 | 0.180 |
Why?
|
Proteomics | 5 | 2024 | 3849 | 0.180 |
Why?
|
Pyrimethamine | 1 | 2021 | 94 | 0.180 |
Why?
|
Virus Latency | 1 | 2023 | 363 | 0.180 |
Why?
|
Treatment Failure | 2 | 2024 | 2645 | 0.180 |
Why?
|
Cell Tracking | 1 | 2022 | 139 | 0.180 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2023 | 5315 | 0.180 |
Why?
|
Genome-Wide Association Study | 3 | 2019 | 12690 | 0.180 |
Why?
|
Aged | 28 | 2024 | 169289 | 0.180 |
Why?
|
Aged, 80 and over | 14 | 2024 | 58976 | 0.170 |
Why?
|
Social Sciences | 1 | 2020 | 40 | 0.170 |
Why?
|
Tumor Virus Infections | 1 | 2023 | 438 | 0.170 |
Why?
|
Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2000 | 67 | 0.170 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2000 | 71 | 0.170 |
Why?
|
Therapies, Investigational | 1 | 2021 | 111 | 0.170 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2023 | 1606 | 0.170 |
Why?
|
Chemokines | 1 | 2024 | 960 | 0.170 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2021 | 718 | 0.170 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2022 | 259 | 0.170 |
Why?
|
Leukemia, Myeloid | 2 | 2021 | 694 | 0.170 |
Why?
|
Cells, Cultured | 7 | 2020 | 18965 | 0.170 |
Why?
|
Cell Proliferation | 4 | 2021 | 10445 | 0.170 |
Why?
|
Technology | 1 | 2022 | 292 | 0.170 |
Why?
|
Lung Neoplasms | 6 | 2023 | 13380 | 0.170 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2022 | 318 | 0.160 |
Why?
|
CpG Islands | 3 | 2024 | 1230 | 0.160 |
Why?
|
Rhabdoid Tumor | 1 | 2021 | 210 | 0.160 |
Why?
|
Cell Differentiation | 5 | 2022 | 11528 | 0.160 |
Why?
|
RNA Polymerase III | 1 | 2018 | 58 | 0.150 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 3 | 2020 | 899 | 0.150 |
Why?
|
Small Ubiquitin-Related Modifier Proteins | 1 | 2018 | 68 | 0.150 |
Why?
|
Immunity, Cellular | 2 | 2014 | 1560 | 0.150 |
Why?
|
Blotting, Western | 4 | 2011 | 5035 | 0.150 |
Why?
|
Organoids | 1 | 2024 | 740 | 0.150 |
Why?
|
Chromosome Deletion | 4 | 2020 | 1386 | 0.150 |
Why?
|
Neoplasm Transplantation | 1 | 2021 | 2016 | 0.150 |
Why?
|
Immunoglobulin Variable Region | 3 | 2023 | 419 | 0.150 |
Why?
|
Phospholipase C gamma | 1 | 2017 | 131 | 0.150 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 4575 | 0.140 |
Why?
|
Gene Expression Regulation | 5 | 2023 | 11903 | 0.140 |
Why?
|
Chromatography, Liquid | 2 | 2021 | 983 | 0.140 |
Why?
|
Benzamides | 5 | 2012 | 1370 | 0.140 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 496 | 0.140 |
Why?
|
Flow Cytometry | 4 | 2022 | 5869 | 0.140 |
Why?
|
Cloning, Molecular | 3 | 2019 | 4174 | 0.140 |
Why?
|
Introns | 1 | 2020 | 981 | 0.140 |
Why?
|
HEK293 Cells | 2 | 2018 | 4278 | 0.140 |
Why?
|
Viral Envelope Proteins | 1 | 2020 | 640 | 0.140 |
Why?
|
Myocarditis | 1 | 2024 | 788 | 0.140 |
Why?
|
Jurkat Cells | 1 | 2018 | 740 | 0.140 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2020 | 1435 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 17904 | 0.140 |
Why?
|
Dendritic Cells | 6 | 2024 | 2747 | 0.140 |
Why?
|
Hematopoiesis | 2 | 2023 | 2049 | 0.140 |
Why?
|
Survival Rate | 6 | 2021 | 12725 | 0.140 |
Why?
|
Epidemiology | 1 | 2019 | 279 | 0.140 |
Why?
|
Pericardial Effusion | 1 | 1998 | 247 | 0.140 |
Why?
|
STAT3 Transcription Factor | 1 | 2021 | 871 | 0.140 |
Why?
|
Receptor, Notch1 | 1 | 2019 | 496 | 0.130 |
Why?
|
Drug Monitoring | 1 | 2002 | 962 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 736 | 0.130 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2020 | 1693 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2024 | 2330 | 0.130 |
Why?
|
Hemangiosarcoma | 1 | 1998 | 215 | 0.130 |
Why?
|
Mice, SCID | 1 | 2021 | 2626 | 0.130 |
Why?
|
Software | 6 | 2023 | 4434 | 0.130 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1410 | 0.130 |
Why?
|
Histiocytic Sarcoma | 1 | 2016 | 40 | 0.130 |
Why?
|
Pathology, Molecular | 1 | 2019 | 328 | 0.130 |
Why?
|
Cell Line | 6 | 2023 | 15601 | 0.130 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 2020 | 410 | 0.130 |
Why?
|
RNA Transport | 1 | 2015 | 45 | 0.130 |
Why?
|
Mice, Knockout | 5 | 2024 | 14414 | 0.130 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1745 | 0.130 |
Why?
|
Complementarity Determining Regions | 1 | 2016 | 149 | 0.130 |
Why?
|
Amino Acid Sequence | 6 | 2018 | 13446 | 0.130 |
Why?
|
Microsatellite Instability | 2 | 2018 | 716 | 0.130 |
Why?
|
Lymph Nodes | 3 | 2023 | 3466 | 0.130 |
Why?
|
Lymphoma | 2 | 2022 | 1901 | 0.130 |
Why?
|
Immunologic Surveillance | 1 | 2016 | 92 | 0.130 |
Why?
|
Immunomodulation | 1 | 2019 | 549 | 0.120 |
Why?
|
Interleukin-2 | 1 | 2022 | 1889 | 0.120 |
Why?
|
Hematopoietic Stem Cells | 3 | 2016 | 3396 | 0.120 |
Why?
|
DNA Polymerase II | 1 | 2015 | 104 | 0.120 |
Why?
|
Cyclophilin A | 1 | 2015 | 58 | 0.120 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2022 | 891 | 0.120 |
Why?
|
Heart Neoplasms | 1 | 1998 | 362 | 0.120 |
Why?
|
Cell Transdifferentiation | 1 | 2016 | 185 | 0.120 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2017 | 212 | 0.120 |
Why?
|
Molecular Sequence Data | 8 | 2014 | 17635 | 0.120 |
Why?
|
PTEN Phosphohydrolase | 2 | 2020 | 1115 | 0.120 |
Why?
|
Mutation, Missense | 3 | 2014 | 2571 | 0.120 |
Why?
|
Transplantation, Isogeneic | 2 | 2012 | 248 | 0.120 |
Why?
|
Sulfites | 1 | 2014 | 83 | 0.120 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2023 | 4026 | 0.120 |
Why?
|
Biomarkers, Pharmacological | 1 | 2015 | 161 | 0.120 |
Why?
|
Gene Deletion | 2 | 2020 | 2665 | 0.120 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2017 | 452 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2014 | 3778 | 0.120 |
Why?
|
Case-Control Studies | 6 | 2024 | 22176 | 0.120 |
Why?
|
Lymphocytes | 3 | 2012 | 2612 | 0.120 |
Why?
|
Remission Induction | 4 | 2012 | 2396 | 0.120 |
Why?
|
Immunosuppressive Agents | 3 | 2018 | 4174 | 0.120 |
Why?
|
Neoadjuvant Therapy | 2 | 2023 | 2827 | 0.120 |
Why?
|
Thiophenes | 1 | 2018 | 569 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 1 | 2023 | 1159 | 0.110 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2021 | 15936 | 0.110 |
Why?
|
Oncogenes | 2 | 2024 | 1222 | 0.110 |
Why?
|
Vaccines | 1 | 2022 | 844 | 0.110 |
Why?
|
Protein Multimerization | 1 | 2018 | 983 | 0.110 |
Why?
|
Ubiquitin | 1 | 2018 | 839 | 0.110 |
Why?
|
Mutant Proteins | 2 | 2018 | 491 | 0.110 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2020 | 926 | 0.110 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14605 | 0.110 |
Why?
|
Genotype | 2 | 2024 | 12990 | 0.110 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2020 | 1085 | 0.110 |
Why?
|
Proto-Oncogene Proteins | 4 | 2019 | 4511 | 0.110 |
Why?
|
Ribosomal Proteins | 1 | 2015 | 371 | 0.110 |
Why?
|
Biological Products | 1 | 2022 | 914 | 0.110 |
Why?
|
Ecosystem | 1 | 2017 | 490 | 0.110 |
Why?
|
Combined Modality Therapy | 4 | 2022 | 8529 | 0.110 |
Why?
|
Survival Analysis | 4 | 2021 | 10090 | 0.110 |
Why?
|
Nanowires | 1 | 2012 | 31 | 0.110 |
Why?
|
Leiomyosarcoma | 1 | 2017 | 422 | 0.110 |
Why?
|
Antigens, CD19 | 3 | 2023 | 424 | 0.100 |
Why?
|
Antigens | 3 | 2022 | 1443 | 0.100 |
Why?
|
Histone Deacetylases | 1 | 2017 | 719 | 0.100 |
Why?
|
Telomere | 1 | 2019 | 943 | 0.100 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2015 | 416 | 0.100 |
Why?
|
Chromosome Aberrations | 2 | 2021 | 1768 | 0.100 |
Why?
|
Ovarian Neoplasms | 2 | 2022 | 4876 | 0.100 |
Why?
|
Transcription Factors | 5 | 2023 | 12128 | 0.100 |
Why?
|
Vaccines, Subunit | 2 | 2023 | 161 | 0.100 |
Why?
|
Nuclear Proteins | 3 | 2023 | 5796 | 0.100 |
Why?
|
Silicon | 1 | 2012 | 142 | 0.100 |
Why?
|
Cyclophosphamide | 3 | 2023 | 2218 | 0.100 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2013 | 297 | 0.100 |
Why?
|
Biopsy | 2 | 2023 | 6766 | 0.100 |
Why?
|
Sarcoma | 1 | 2023 | 1801 | 0.100 |
Why?
|
Myocardium | 1 | 2024 | 4726 | 0.100 |
Why?
|
Blood Donors | 1 | 2013 | 345 | 0.100 |
Why?
|
Lymphocyte Count | 1 | 2013 | 778 | 0.100 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2016 | 478 | 0.100 |
Why?
|
Ligands | 3 | 2024 | 3272 | 0.100 |
Why?
|
Selection, Genetic | 1 | 2016 | 868 | 0.100 |
Why?
|
Adjuvants, Immunologic | 2 | 2020 | 1036 | 0.100 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2019 | 1351 | 0.090 |
Why?
|
Chemokine CCL3 | 1 | 2011 | 84 | 0.090 |
Why?
|
Models, Immunological | 2 | 2014 | 513 | 0.090 |
Why?
|
DNA Mutational Analysis | 4 | 2017 | 4111 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2020 | 2909 | 0.090 |
Why?
|
Graft Rejection | 4 | 2008 | 4445 | 0.090 |
Why?
|
BRCA2 Protein | 1 | 2016 | 805 | 0.090 |
Why?
|
Databases as Topic | 1 | 2013 | 473 | 0.090 |
Why?
|
Plasma Cells | 2 | 2005 | 599 | 0.090 |
Why?
|
Carcinoma | 1 | 2022 | 2330 | 0.090 |
Why?
|
CD40 Ligand | 1 | 2012 | 522 | 0.090 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 22169 | 0.090 |
Why?
|
Immunoglobulin Isotypes | 1 | 1991 | 158 | 0.090 |
Why?
|
Radionuclide Imaging | 1 | 2014 | 1972 | 0.090 |
Why?
|
Cyclosporine | 2 | 2008 | 778 | 0.090 |
Why?
|
Cell Compartmentation | 1 | 2011 | 384 | 0.090 |
Why?
|
Twins | 1 | 2012 | 339 | 0.090 |
Why?
|
Protein Binding | 2 | 2014 | 9351 | 0.090 |
Why?
|
Thalassemia | 1 | 2011 | 267 | 0.090 |
Why?
|
Autophagy | 1 | 2018 | 1326 | 0.090 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.090 |
Why?
|
Macrophages | 2 | 2024 | 5769 | 0.090 |
Why?
|
Stromal Cells | 2 | 2012 | 1330 | 0.080 |
Why?
|
Phylogeny | 1 | 2017 | 2811 | 0.080 |
Why?
|
Chemokine CXCL10 | 1 | 2011 | 316 | 0.080 |
Why?
|
Heart Transplantation | 2 | 1994 | 3233 | 0.080 |
Why?
|
Tacrolimus | 2 | 2023 | 733 | 0.080 |
Why?
|
Documentation | 2 | 2013 | 897 | 0.080 |
Why?
|
Alleles | 2 | 2019 | 6863 | 0.080 |
Why?
|
B-Lymphocyte Subsets | 1 | 1991 | 239 | 0.080 |
Why?
|
BRCA1 Protein | 1 | 2016 | 1155 | 0.080 |
Why?
|
Bone Marrow Cells | 2 | 2013 | 2416 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2895 | 0.080 |
Why?
|
Erythema | 1 | 2010 | 262 | 0.080 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2009 | 188 | 0.080 |
Why?
|
Immunodominant Epitopes | 1 | 2010 | 239 | 0.080 |
Why?
|
Killer Cells, Natural | 3 | 2023 | 2200 | 0.080 |
Why?
|
Chromosomes, Human, Y | 1 | 2010 | 161 | 0.080 |
Why?
|
Histocompatibility | 1 | 2010 | 317 | 0.080 |
Why?
|
Interferon-alpha | 2 | 2011 | 921 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 1486 | 0.080 |
Why?
|
Adenocarcinoma | 2 | 2016 | 6346 | 0.080 |
Why?
|
RNA Interference | 2 | 2014 | 2831 | 0.080 |
Why?
|
Young Adult | 10 | 2024 | 59243 | 0.080 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 1741 | 0.080 |
Why?
|
Medical Oncology | 1 | 2020 | 2321 | 0.080 |
Why?
|
Energy Metabolism | 1 | 2019 | 2882 | 0.080 |
Why?
|
Nucleic Acids | 1 | 2011 | 188 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2023 | 1135 | 0.080 |
Why?
|
Stem Cells | 1 | 2021 | 3522 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3575 | 0.080 |
Why?
|
Cohort Studies | 5 | 2020 | 41487 | 0.080 |
Why?
|
rab GTP-Binding Proteins | 1 | 2010 | 250 | 0.080 |
Why?
|
T-Lymphocyte Subsets | 1 | 2016 | 1802 | 0.070 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2010 | 368 | 0.070 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1420 | 0.070 |
Why?
|
Reproducibility of Results | 3 | 2019 | 20098 | 0.070 |
Why?
|
Myeloablative Agonists | 1 | 2008 | 209 | 0.070 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2023 | 647 | 0.070 |
Why?
|
Bone Marrow | 3 | 2024 | 2911 | 0.070 |
Why?
|
Melanosomes | 1 | 2007 | 33 | 0.070 |
Why?
|
Workflow | 1 | 2012 | 851 | 0.070 |
Why?
|
Tumor Burden | 1 | 2013 | 1893 | 0.070 |
Why?
|
Exoribonucleases | 2 | 2005 | 93 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 4 | 2021 | 2803 | 0.070 |
Why?
|
Pulmonary Edema | 1 | 2010 | 409 | 0.070 |
Why?
|
Saccharomyces cerevisiae | 1 | 2018 | 2688 | 0.070 |
Why?
|
Histocompatibility Testing | 2 | 2019 | 712 | 0.070 |
Why?
|
Models, Genetic | 1 | 2017 | 3442 | 0.070 |
Why?
|
Blood Group Incompatibility | 1 | 2008 | 135 | 0.070 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6814 | 0.070 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2021 | 455 | 0.070 |
Why?
|
src-Family Kinases | 1 | 2010 | 535 | 0.070 |
Why?
|
Peptide Mapping | 1 | 2007 | 262 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 8002 | 0.070 |
Why?
|
Child | 8 | 2024 | 80153 | 0.070 |
Why?
|
Mycophenolic Acid | 1 | 2008 | 348 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 2 | 2021 | 2469 | 0.070 |
Why?
|
Immunoglobulin G | 5 | 2011 | 4544 | 0.070 |
Why?
|
Endometrial Neoplasms | 1 | 2015 | 1366 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2811 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2010 | 727 | 0.070 |
Why?
|
Time Factors | 6 | 2019 | 39967 | 0.060 |
Why?
|
Child, Preschool | 5 | 2024 | 42230 | 0.060 |
Why?
|
Immunity, Humoral | 1 | 2010 | 606 | 0.060 |
Why?
|
Organelles | 1 | 2007 | 266 | 0.060 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1505 | 0.060 |
Why?
|
H-Y Antigen | 1 | 2004 | 42 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 3 | 2021 | 6484 | 0.060 |
Why?
|
Molecular Chaperones | 1 | 2010 | 754 | 0.060 |
Why?
|
Promoter Regions, Genetic | 3 | 2019 | 5789 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8654 | 0.060 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2017 | 2223 | 0.060 |
Why?
|
Graft vs Tumor Effect | 1 | 2005 | 68 | 0.060 |
Why?
|
Adolescent | 8 | 2024 | 88319 | 0.060 |
Why?
|
Ventricular Myosins | 1 | 2024 | 65 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2023 | 21012 | 0.060 |
Why?
|
RNA, Transfer, Leu | 1 | 2024 | 13 | 0.060 |
Why?
|
Sialoglycoproteins | 1 | 2005 | 315 | 0.060 |
Why?
|
Cell Survival | 1 | 2014 | 5791 | 0.060 |
Why?
|
Receptors, Transferrin | 1 | 2005 | 291 | 0.060 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39106 | 0.050 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2020 | 1320 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3429 | 0.050 |
Why?
|
Protein Biosynthesis | 1 | 2011 | 2113 | 0.050 |
Why?
|
Gene Expression | 5 | 2019 | 7581 | 0.050 |
Why?
|
Roseolovirus Infections | 1 | 2023 | 49 | 0.050 |
Why?
|
Palatine Tonsil | 1 | 2023 | 193 | 0.050 |
Why?
|
Antibody Specificity | 1 | 2005 | 1060 | 0.050 |
Why?
|
STAT Transcription Factors | 1 | 2023 | 188 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2023 | 2872 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7407 | 0.050 |
Why?
|
Blood Proteins | 1 | 2008 | 1173 | 0.050 |
Why?
|
Fever | 1 | 2010 | 1618 | 0.050 |
Why?
|
Globins | 1 | 2003 | 404 | 0.050 |
Why?
|
Janus Kinases | 1 | 2023 | 248 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2012 | 6534 | 0.050 |
Why?
|
Bone Marrow Examination | 1 | 2002 | 154 | 0.050 |
Why?
|
Thiazoles | 1 | 2010 | 1517 | 0.050 |
Why?
|
Neoplasm Metastasis | 2 | 2024 | 4915 | 0.050 |
Why?
|
Vaccines, DNA | 1 | 2024 | 286 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2005 | 585 | 0.050 |
Why?
|
Response Elements | 1 | 2023 | 309 | 0.050 |
Why?
|
Cross-Priming | 1 | 2022 | 76 | 0.050 |
Why?
|
Culture Media, Conditioned | 1 | 2023 | 522 | 0.050 |
Why?
|
Interleukin-18 | 1 | 2023 | 250 | 0.050 |
Why?
|
Prospective Studies | 5 | 2020 | 54425 | 0.050 |
Why?
|
Cytogenetic Analysis | 1 | 2002 | 270 | 0.050 |
Why?
|
Antigens, Viral, Tumor | 1 | 2022 | 153 | 0.050 |
Why?
|
bcl-X Protein | 1 | 2023 | 410 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2009 | 1616 | 0.050 |
Why?
|
Genetic Markers | 1 | 2008 | 2601 | 0.050 |
Why?
|
Up-Regulation | 1 | 2011 | 4124 | 0.050 |
Why?
|
Leukopoiesis | 1 | 2001 | 54 | 0.050 |
Why?
|
Chemical Fractionation | 1 | 2021 | 61 | 0.050 |
Why?
|
Organ Specificity | 2 | 2023 | 1967 | 0.050 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 2001 | 111 | 0.050 |
Why?
|
Pulmonary Alveoli | 1 | 2024 | 652 | 0.050 |
Why?
|
Cell Cycle Proteins | 2 | 2023 | 3448 | 0.050 |
Why?
|
Erythrocytes | 1 | 2011 | 2413 | 0.050 |
Why?
|
Azacitidine | 1 | 2023 | 336 | 0.050 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2023 | 439 | 0.050 |
Why?
|
Gene Frequency | 1 | 2008 | 3606 | 0.050 |
Why?
|
Telomere-Binding Proteins | 1 | 2021 | 119 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2691 | 0.050 |
Why?
|
Interferon-gamma | 2 | 2023 | 3162 | 0.040 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2000 | 87 | 0.040 |
Why?
|
Life | 1 | 2020 | 13 | 0.040 |
Why?
|
Etoposide | 1 | 2022 | 634 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 14666 | 0.040 |
Why?
|
Autoantigens | 1 | 2024 | 891 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcr | 1 | 2020 | 19 | 0.040 |
Why?
|
DNA Damage | 2 | 2021 | 2446 | 0.040 |
Why?
|
Molecular Sequence Annotation | 2 | 2012 | 522 | 0.040 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2000 | 121 | 0.040 |
Why?
|
Troponin I | 1 | 2024 | 651 | 0.040 |
Why?
|
HLA-A Antigens | 2 | 2011 | 223 | 0.040 |
Why?
|
HLA-A2 Antigen | 2 | 2011 | 211 | 0.040 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2023 | 495 | 0.040 |
Why?
|
Troponin T | 1 | 2024 | 780 | 0.040 |
Why?
|
Ribonuclease H | 1 | 2019 | 50 | 0.040 |
Why?
|
Microscopy | 1 | 2024 | 903 | 0.040 |
Why?
|
Vincristine | 1 | 2022 | 1036 | 0.040 |
Why?
|
Freezing | 1 | 2020 | 311 | 0.040 |
Why?
|
Mice, Nude | 2 | 2020 | 3615 | 0.040 |
Why?
|
Protein Isoforms | 2 | 2020 | 1699 | 0.040 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2019 | 57 | 0.040 |
Why?
|
Incidence | 4 | 2023 | 21353 | 0.040 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2020 | 367 | 0.040 |
Why?
|
DNA Transposable Elements | 1 | 2023 | 755 | 0.040 |
Why?
|
RNA-Binding Proteins | 2 | 2005 | 1897 | 0.040 |
Why?
|
Gene Fusion | 1 | 2022 | 356 | 0.040 |
Why?
|
RNA Splice Sites | 1 | 2020 | 211 | 0.040 |
Why?
|
Genes, Suppressor | 1 | 2018 | 47 | 0.040 |
Why?
|
Drugs, Investigational | 1 | 2021 | 212 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2019 | 11076 | 0.040 |
Why?
|
Drug Repositioning | 1 | 2021 | 233 | 0.040 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 305 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2022 | 558 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2024 | 80636 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2020 | 535 | 0.040 |
Why?
|
Histone Code | 1 | 2019 | 158 | 0.040 |
Why?
|
Interleukins | 2 | 1993 | 782 | 0.040 |
Why?
|
Mice, 129 Strain | 1 | 2019 | 371 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2018 | 6935 | 0.040 |
Why?
|
DNA Modification Methylases | 1 | 2018 | 210 | 0.040 |
Why?
|
Sumoylation | 1 | 2018 | 83 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2023 | 999 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 698 | 0.040 |
Why?
|
DNA-Binding Proteins | 3 | 2020 | 9606 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 976 | 0.040 |
Why?
|
Adaptive Immunity | 1 | 2022 | 726 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2020 | 320 | 0.040 |
Why?
|
Melanocytes | 1 | 2021 | 509 | 0.040 |
Why?
|
Automation | 1 | 2020 | 586 | 0.040 |
Why?
|
Phthalazines | 1 | 2020 | 383 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2019 | 931 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2016 | 800 | 0.040 |
Why?
|
Prednisone | 1 | 2022 | 1563 | 0.040 |
Why?
|
beta 2-Microglobulin | 1 | 2018 | 329 | 0.040 |
Why?
|
Blotting, Southern | 2 | 1994 | 777 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2021 | 1085 | 0.030 |
Why?
|
DNA Repair Enzymes | 1 | 2018 | 346 | 0.030 |
Why?
|
Exons | 1 | 2023 | 2391 | 0.030 |
Why?
|
Biological Clocks | 1 | 2019 | 318 | 0.030 |
Why?
|
Antibodies | 1 | 2005 | 2418 | 0.030 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2017 | 101 | 0.030 |
Why?
|
Peptide Hydrolases | 1 | 2019 | 624 | 0.030 |
Why?
|
Immunoglobulin M | 2 | 2012 | 1527 | 0.030 |
Why?
|
Neutropenia | 1 | 2022 | 885 | 0.030 |
Why?
|
Amino Acids | 1 | 2022 | 1718 | 0.030 |
Why?
|
Reference Values | 2 | 2003 | 4920 | 0.030 |
Why?
|
Cryopreservation | 1 | 2021 | 728 | 0.030 |
Why?
|
Methotrexate | 1 | 2003 | 1719 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2023 | 1264 | 0.030 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2012 | 452 | 0.030 |
Why?
|
Melanoma, Experimental | 1 | 2019 | 560 | 0.030 |
Why?
|
Sirolimus | 1 | 2003 | 1533 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1626 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 2019 | 795 | 0.030 |
Why?
|
Oncolytic Viruses | 1 | 2020 | 344 | 0.030 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 682 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2019 | 1749 | 0.030 |
Why?
|
Drug Synergism | 1 | 2020 | 1755 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2018 | 662 | 0.030 |
Why?
|
Cell Movement | 2 | 2020 | 5203 | 0.030 |
Why?
|
RNA | 2 | 2023 | 2726 | 0.030 |
Why?
|
Isoquinolines | 1 | 2017 | 352 | 0.030 |
Why?
|
Immunoglobulin Class Switching | 1 | 2017 | 289 | 0.030 |
Why?
|
Internet | 1 | 2007 | 3092 | 0.030 |
Why?
|
Doxorubicin | 1 | 2022 | 2224 | 0.030 |
Why?
|
Cytidine Deaminase | 1 | 2017 | 243 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2022 | 2898 | 0.030 |
Why?
|
Recovery of Function | 1 | 2005 | 2979 | 0.030 |
Why?
|
Paclitaxel | 1 | 2022 | 1732 | 0.030 |
Why?
|
Antigens, CD | 1 | 2005 | 4003 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 3702 | 0.030 |
Why?
|
Viral Load | 1 | 2023 | 3332 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2192 | 0.030 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2017 | 237 | 0.030 |
Why?
|
Transplantation Immunology | 1 | 2016 | 532 | 0.030 |
Why?
|
Fibroblasts | 1 | 2024 | 4141 | 0.030 |
Why?
|
Dioxygenases | 1 | 2016 | 345 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2022 | 3514 | 0.030 |
Why?
|
Ubiquitination | 1 | 2018 | 1006 | 0.030 |
Why?
|
DNA Replication Timing | 1 | 2013 | 34 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 2017 | 926 | 0.030 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2013 | 95 | 0.030 |
Why?
|
bcl-Associated Death Protein | 1 | 2012 | 102 | 0.030 |
Why?
|
Gene Silencing | 1 | 2019 | 1509 | 0.030 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2012 | 84 | 0.030 |
Why?
|
Lymphotoxin-alpha | 1 | 1992 | 93 | 0.030 |
Why?
|
Chromosome Duplication | 1 | 2012 | 75 | 0.020 |
Why?
|
DNA Repair | 1 | 2021 | 2045 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2017 | 1519 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2023 | 4352 | 0.020 |
Why?
|
Amino Acid Substitution | 2 | 2010 | 1738 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2021 | 1589 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2016 | 3080 | 0.020 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2012 | 274 | 0.020 |
Why?
|
Heart | 1 | 2024 | 4404 | 0.020 |
Why?
|
Phycoerythrin | 1 | 1991 | 9 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2012 | 295 | 0.020 |
Why?
|
Urinary Bladder | 1 | 2017 | 1152 | 0.020 |
Why?
|
Viral Matrix Proteins | 1 | 2012 | 196 | 0.020 |
Why?
|
Dexamethasone | 1 | 2018 | 1948 | 0.020 |
Why?
|
Immunoglobulin D | 1 | 1991 | 54 | 0.020 |
Why?
|
Point Mutation | 1 | 2016 | 1595 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2012 | 322 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2017 | 1393 | 0.020 |
Why?
|
Cell Cycle | 1 | 2019 | 2932 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2057 | 0.020 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2012 | 357 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2917 | 0.020 |
Why?
|
Hippocampus | 1 | 2023 | 3766 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 1992 | 1302 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2013 | 957 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2017 | 2707 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1611 | 0.020 |
Why?
|
Chemokine CXCL12 | 1 | 2012 | 454 | 0.020 |
Why?
|
United States | 2 | 2021 | 72334 | 0.020 |
Why?
|
Genetic Loci | 1 | 2019 | 2632 | 0.020 |
Why?
|
Macaca fascicularis | 1 | 1992 | 903 | 0.020 |
Why?
|
Infant | 2 | 2024 | 36192 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2016 | 2571 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7212 | 0.020 |
Why?
|
Myeloproliferative Disorders | 1 | 2016 | 613 | 0.020 |
Why?
|
Sample Size | 1 | 2013 | 841 | 0.020 |
Why?
|
Chimera | 1 | 2011 | 453 | 0.020 |
Why?
|
Placenta | 1 | 2018 | 1709 | 0.020 |
Why?
|
Threonine | 1 | 2010 | 271 | 0.020 |
Why?
|
Testis | 2 | 2004 | 794 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2018 | 1841 | 0.020 |
Why?
|
Family | 1 | 2020 | 3194 | 0.020 |
Why?
|
Reference Standards | 1 | 2012 | 1003 | 0.020 |
Why?
|
Metagenomics | 1 | 2012 | 467 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2015 | 1118 | 0.020 |
Why?
|
Histones | 1 | 2019 | 2580 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10766 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2012 | 1341 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2012 | 988 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7237 | 0.020 |
Why?
|
Antibody Formation | 2 | 2003 | 1395 | 0.020 |
Why?
|
Age Factors | 1 | 2024 | 18395 | 0.020 |
Why?
|
Cell Count | 1 | 2011 | 1835 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9646 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2017 | 3712 | 0.020 |
Why?
|
Career Choice | 1 | 2012 | 756 | 0.020 |
Why?
|
Molecular Structure | 1 | 2010 | 1880 | 0.020 |
Why?
|
Genetic Testing | 1 | 2018 | 3537 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2012 | 5112 | 0.020 |
Why?
|
Boronic Acids | 1 | 2009 | 915 | 0.020 |
Why?
|
Lung | 1 | 2023 | 10000 | 0.020 |
Why?
|
Computer Simulation | 1 | 2018 | 6240 | 0.010 |
Why?
|
Artifacts | 1 | 2013 | 1911 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 9000 | 0.010 |
Why?
|
Precancerous Conditions | 1 | 2011 | 980 | 0.010 |
Why?
|
Syndrome | 1 | 2010 | 3267 | 0.010 |
Why?
|
Lung Transplantation | 1 | 1993 | 1310 | 0.010 |
Why?
|
B-Cell Maturation Antigen | 1 | 2005 | 149 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15266 | 0.010 |
Why?
|
Pyrazines | 1 | 2009 | 1201 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1998 | 12974 | 0.010 |
Why?
|
Transfection | 1 | 2011 | 5774 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2735 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3810 | 0.010 |
Why?
|
Drug Discovery | 1 | 2010 | 1051 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1991 | 6216 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2011 | 2303 | 0.010 |
Why?
|
Phosphorylation | 1 | 2012 | 8320 | 0.010 |
Why?
|
MicroRNAs | 1 | 2017 | 3816 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11121 | 0.010 |
Why?
|
Isoantibodies | 1 | 2004 | 674 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2002 | 1545 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2002 | 1991 | 0.010 |
Why?
|
Proteins | 1 | 2012 | 6032 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 29874 | 0.010 |
Why?
|
Brain | 1 | 2023 | 27112 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2002 | 1475 | 0.010 |
Why?
|
Cell Membrane | 1 | 2005 | 3688 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2001 | 2510 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2003 | 6310 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2001 | 4615 | 0.010 |
Why?
|
Aging | 1 | 2010 | 8708 | 0.010 |
Why?
|
Chronic Disease | 1 | 2004 | 9318 | 0.010 |
Why?
|
Risk Factors | 1 | 2010 | 74206 | 0.000 |
Why?
|